Assessing a Dose-Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients
Clinical trial NCT03423810 · COMPLETED
Trial details
- NCT number
- NCT03423810
- Sponsor
- University of Kansas Medical Center
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-23
- Primary completion
- 2020-01-30
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.